Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $3.6 million.

  • Regenxbio's Interest & Investment Income rose 1050.06% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year increase of 6422.83%. This contributed to the annual value of $18.7 million for FY2024, which is 6546.51% up from last year.
  • As of Q3 2025, Regenxbio's Interest & Investment Income stood at $3.6 million, which was up 1050.06% from $3.4 million recorded in Q2 2025.
  • Regenxbio's Interest & Investment Income's 5-year high stood at $9.5 million during Q4 2024, with a 5-year trough of $311000.0 in Q4 2021.
  • Its 5-year average for Interest & Investment Income is $2.7 million, with a median of $2.4 million in 2023.
  • Per our database at Business Quant, Regenxbio's Interest & Investment Income plummeted by 9774.54% in 2021 and then soared by 55144.69% in 2022.
  • Over the past 5 years, Regenxbio's Interest & Investment Income (Quarter) stood at $311000.0 in 2021, then surged by 551.45% to $2.0 million in 2022, then grew by 16.78% to $2.4 million in 2023, then skyrocketed by 302.2% to $9.5 million in 2024, then plummeted by 61.96% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $3.4 million for Q2 2025, and $2.5 million during Q1 2025.